SPHK1 and metastatic malignant neoplasm in the lymph nodes: This analysis also demonstrated that high SPHK1 expression in cervical cancer had the highest relative risk of recurrence (3.604), superior to the risk associated with lymph node metastasis (2.483) or lymphovascular invasion (2.716).